산부인과 질환에서 내분비 장애물질의 유전외적 조절: 프탈레이트를 중심으로

키워드

참고문헌 (69)

1. 이철우, "내분비계장애물질에 대한 이해와 미래 연구방향", Endocrinology and Metabolism, 24(1), pp.7~14 (2009), 대한내분비학회
2. Newbold R, "Cellular and molecular effects of developmental exposure to diethylstilbestrol: implications for other environmental estrogens", Environ Health Perspect, 103(7), pp.83~87 (1995)
3. Yang JZ, "Subchronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin modulates the pathophysiology of endometriosis in the cynomolgus monkey", Toxicol Sci, 56, pp.374~381 (2000)
4. Cobellis L, "High plasma concentrations of di-(2-ethylhexyl)-phthalate in women with endometriosis", Hum Reprod, 18, pp.1512~1515 (2003)
5. Reddy BS, "Association of phthalate esters with endometriosis in Indian women", BJOG, 113, pp.515~520 (2006)
6. Rasier G, "Early maturation of gonadotropin-releasing hormone secretion and sexual precocity after exposure of infant female rats to estradiol or dichlorodiphenyltrichloroethane", Biol Reprod, 77, pp.734~742 (2007)
7. Howdeshell KL, "Exposure to bisphenol A advances puberty", Nature, 401, pp.763~764 (1999)
8. Krstevska-Konstantinova M, "Sexual precocity after immigration from developing countries to Belgium: evidence of previous exposure to organochlorine pesticides", Hum Reprod, 16, pp.1020~1026 (2001)
9. Blanck HM, "Age at menarche and tanner stage in girls exposed in utero and postnatally to polybrominated biphenyl", Epidemiology, 11, pp.641~647 (2000)
10. Colón I, "Identification of phthalate esters in the serum of young Puerto Rican girls with premature breast development", Environ Health Perspect, 108, pp.895~900 (2000)
11. Türkyilmaz Z, "A striking and frequent cause of premature thelarche in children: Foeniculum vulgare", J Pediatr Surg, 43, pp.2109~2111 (2008)
12. Martin OV, "Human health and endocrine disruption: a simple multicriteria framework for the qualitative assessment of end point specific risks in a context of scientific uncertainty", Toxicol Sci, 98, pp.332~347 (2007)
13. Jenkins S, "Prenatal TCDD exposure predisposes for mammary cancer in rats", Reprod Toxicol, 23, pp.391~396 (2007)
14. Murray TJ, "Induction of mammary gland ductal hyperplasias and carcinoma in situ following fetal bisphenol A exposure", Reprod Toxicol, 23, pp.383~390 (2007)
15. Vandenberg LN, "Perinatal exposure to the xenoestrogen bisphenol-A induces mammary intraductal hyperplasias in adult CD-1 mice", Reprod Toxicol, 26, pp.210~219 (2008)
16. Caserta D, "Impact of endocrine disruptor chemicals in gynaecology", Hum Reprod Update, 14, pp.59~72 (2008)
17. Mahoney MM, "Developmental programming: impact of fetal exposure to endocrine-disrupting chemicals on gonadotropin-releasing hormone and estrogen receptor mRNA in sheep hypothalamus", Toxicol Appl Pharmacol, 247, pp.98~104 (2010)
18. Bellingham M, "Exposure to a complex cocktail of environmental endocrine-disrupting compounds disturbs the kisspeptin", GPR54 system in ovine hypothalamus and pituitary gland, 2009, pp.117, 1556~1562
19. Dickerson SM, "Prenatal PCBs disrupt early neuroendocrine development of the rat hypothalamus", Toxicol Appl Pharmacol, 252, pp.36~46 (2011)
20. Swan SH, "Decrease in anogenital distance among male infants with prenatal phthalate exposure", Environ Health Perspect, 113, pp.1056~1061 (2005)
21. Kaufman RH, "Structural changes of the genital tract associated with in utero exposure to diethylstilbestrol", Obstet Gynecol Annu, 11, pp.187~202 (1982)
22. Fowler PA, "Impact of endocrine-disrupting compounds (EDCs) on female reproductive health", Mol Cell Endocrinol, 355, pp.231~239 (2012)
23. Diamanti-Kandarakis E, "Endocrine-disrupting chemicals: an Endocrine Society scientific statement", Endocr Rev, 30, pp.293~342 (2009)
24. Parmar D, "Hepatic mixed function oxidases and cytochrome P-450 contents in rat pups exposed to di-(2-ethylhexyl)phthalate through mother’s milk", Drug Metab Dispos, 13, pp.368~370 (1985)
25. Singh AR, "Maternal-fetal transfer of 14C-di-2-ethylhexyl phthalate and 14C-diethyl phthalate in rats", J Pharm Sci, 64, pp.1347~1350 (1975)
26. Kremer JJ, "Pharmacokinetics of monobutylphthalate, the active metabolite of di-nbutylphthalate, in pregnant rats", Toxicol Lett, 159, pp.144~153 (2005)
27. Fennell TR, "Pharmacokinetics of dibutylphthalate in pregnant rats", Toxicol Sci, 82, pp.407~418 (2004)
28. Kessler W, "Blood burden of di(2-ethylhexyl) phthalate and its primary metabolite mono(2-ethylhexyl) phthalate in pregnant and nonpregnant rats and marmosets", Toxicol Appl Pharmacol, 195, pp.142~153 (2004)
29. Calafat AM, "Urinary and amniotic fluid levels of phthalate monoesters in rats after the oral administration of di(2-ethylhexyl) phthalate and di-n-butyl phthalate", Toxicology, 217, pp.22~30 (2006)
30. Ema M, "Characterization of developmental toxicity of mono-n-benzyl phthalate in rats", Reprod Toxicol, 10, pp.365~372 (1996)
31. Saillenfait AM, "Effects of mono-n-butyl phthalate on the development of rat embryos: in vivo and in vitro observations", Pharmacol Toxicol, 89, pp.104~112 (2001)
32. Ema M, "Teratogenic phase specificity of butyl benzyl phthalate in rats", Toxicology, 79, pp.11~19 (1993)
33. Singh AR, "Teratogenicity of phthalate esters in rats", J Pharm Sci, 61, pp.51~55 (1972)
34. Pan G, "Decreased serum free testosterone in workers exposed to high levels of di-n-butyl phthalate (DBP) and di-2-ethylhexyl phthalate (DEHP): a cross-sectional study in China", Environ Health Perspect, 114, pp.1643~1648 (2006)
35. Wormuth M, "What are the sources of exposure to eight frequently used phthalic acid esters in Europeans?", Risk Anal, 26, pp.803~824 (2006)
36. Lyche JL, "Reproductive and developmental toxicity of phthalates", J Toxicol Environ Health B Crit Rev, 12, pp.225~249 (2009)
37. Cresteil T, "Onset of xenobiotic metabolism in children: toxicological implications", Food Addit Contam, 15, pp.45~51 (1998)
38. Agency for Toxic Substances and Disease Registry (ATSDR), "Toxicological profile for di(2-ethylhexyl)phthalate (DEHP)" (2002), U.S. Department of Health and Human Services, Public Health Service
39. Shea KM; American Academy of Pediatrics Committee on Environmental Health, "Pediatric exposure and potential toxicity of phthalate plasticizers", Pediatrics, 111, pp.1467~1474 (2003)
40. Sjoberg P, "Dispositions of di- and mono-(2-ethylhexyl) phthalate in newborn infants subjected to exchange transfusions", Eur J Clin Invest, 15, pp.430~436 (1985)
41. Sjoberg PO, "Exposure of newborn infants to plasticizers. Plasma levels of di-(2-ethylhexyl) phthalate and mono-(2-ethylhexyl) phthalate during exchange transfusion", Transfusion, 25, pp.424~428 (1985)
42. Clark K, "Observed concentrations in the environment. In: Staples CA, editor. Phthalate esters, In The handbook of environmental chemistry. Volume 3Q", pp.125~177 (2003), Springer
43. Kim YH, "Increased viability of endometrial cells by in vitro treatment with di-(2-ethylhexyl) phthalate", Fertil Steril, 94, pp.2413~2416 (2010)
44. Rossing MA, "Risk of epithelial ovarian cancer in relation to benign ovarian conditions and ovarian surgery", Cancer Causes Control, 19, pp.1357~1364 (2008)
45. Merritt MA, "Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer", Int J Cancer, 122, pp.170~176 (2008)
46. Brinton LA, "Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors", Cancer Epidemiol Biomarkers Prev, 14, pp.2929~2935 (2005)
47. Fukunaga M, "Ovarian atypical endometriosis: its close association with malignant epithelial tumours", Histopathology, 30, pp.249~255 (1997)
48. Pearce CL, "Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies", Lancet Oncol, 13, pp.385~394 (2012)
49. Ness RB, "Endometriosis and ovarian cancer: thoughts on shared pathophysiology", Am J Obstet Gynecol, 189, pp.280~294 (2003)
50. Kurman RJ, "Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm", Hum Pathol, 42, pp.918~931 (2011)
51. Wiegand KC, "ARID1A mutations in endometriosis-associated ovarian carcinomas", N Engl J Med, 363, pp.1532~1543 (2010)
52. Yamaguchi K, "Contents of endometriotic cysts, especially the high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the iron-induced persistent oxidative stress", Clin Cancer Res, 14, pp.32~40 (2008)
53. "Polycholorinated dibenxo-para-dioxins and polychlorinated dibenxofurans" (2012)[URL]
54. The january 2001 addendum to the ninth report on carcinogens (originally published May 2000), US HHS, Public Health Service, National Toxicology Program, Research Triangle Park, "National Toxicology Program", ~ (2001)
55. Meeks JJ, "Environmental toxicology of testicular cancer", Urol Oncol, 30, pp.212~215 (2012)
56. Yao PL, "Mono-(2-ethylhexyl) phthalate (MEHP) promotes invasion and migration of human testicular embryonal carcinoma cells", Biol Reprod, 86, pp.160~ (2012)
57. Park MA, "Cell growth of BG-1 ovarian cancer cells is promoted by di-n-butyl phthalate and hexabromocyclododecane via upregulation of the cyclin D and cyclin-dependent kinase-4 genes", Mol Med Report, 5, pp.761~766 (2012)
58. Campioli E, "The endocrine disruptor mono-(2-ethylhexyl) phthalate affects the differ entiation of human liposarcoma cells (SW 872)", PLoS One, 6, pp.28750~ (2011)
59. Dolinoy DC, "Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development", Proc Natl Acad Sci U S A, 104, pp.13056~13061 (2007)
60. Ho SM, "Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4", Cancer Res, 66, pp.5624~5632 (2006)
61. Newbold RR, "Lessons learned from perinatal exposure to diethylstilbestrol", Toxicol Appl Pharmacol, 199, pp.142~150 (2004)
62. Alworth LC, "Uterine responsiveness to estradiol and DNA methylation are altered by fetal exposure to diethylstilbestrol and methoxychlor in CD-1 mice: effects of low versus high doses", Toxicol Appl Pharmacol, 183, pp.10~22 (2002)
63. Zama AM, "Fetal and neonatal exposure to the endocrine disruptor methoxychlor causes epigenetic alterations in adult ovarian genes", Endocrinology, 150, pp.4681~4691 (2009)
64. Tang WY, "Persistent hypomethylation in the promoter of nucleosomal binding protein 1 (Nsbp1) correlates with overexpression of Nsbp1 in mouse uteri neonatally exposed to diethylstilbestrol or genistein", Endocrinology, 149, pp.5922~5931 (2008)
65. Anway MD, "Epigenetic transgenerational actions of endocrine disruptors and male fertility", Science, 308, pp.1466~1469 (2005)
66. Newbold RR, "Adverse effects of the model environmental estrogen diethylstilbestrol are transmitted to subsequent generations", Endocrinology, 147, pp.11~17 (2006)
67. Stouder C, "Transgenerational effects of the endocrine disruptor vinclozolin on the methylation pattern of imprinted genes in the mouse sperm", Reproduction, 139, pp.373~379 (2010)
68. Salian S, "Perinatal exposure of rats to Bisphenol A affects the fertility of male offspring", Life Sci, 85, pp.742~752 (2009)
69. Nilsson EE, "Transgenerational epigenetic effects of the endocrine disruptor vinclozolin on pregnancies and female adult onset disease", Reproduction, 135, pp.713~721 (2008)

관련 논문AI추천